Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 4/8/22 → 1/30/27 |
Funding
- Astellas Pharma Global Development Incorporated: $227,717.00
A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination with Pembrolizumab in Participants with Locally Advanced or Metastatic Solid Tumors
- Villano, PhD, John (PI)
- Chauhan, Aman (Former PI)